HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Lejeune Selected Research

Neoplasms (Cancer)

11/2001On the release and half-life of S100B protein in the peripheral blood of melanoma patients.
7/2001Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients.
6/2001Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
6/2001Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216.
3/2001Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
12/2000Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
8/2000Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
7/2000Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
1/2000Immune monitoring in cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Lejeune Research Topics

Disease

9Neoplasms (Cancer)
11/2001 - 01/2000
8Melanoma (Melanoma, Malignant)
01/2013 - 07/2000
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1Critical Illness (Critically Ill)
01/2020
1Bipolar Disorder (Manic Depressive Psychosis)
02/2018
1Poisoning
02/2018
1Sepsis (Septicemia)
03/2015
1Pressure Ulcer (Bedsore)
03/2015
1Infectious Arthritis (Septic Arthritis)
03/2015
1Neoplasm Micrometastasis
01/2013
1Cardiotoxicity
07/2005
1Sarcoma (Soft Tissue Sarcoma)
07/2005
1Human Influenza (Influenza)
06/2001
1Testicular Neoplasms (Testicular Cancer)
08/2000
1Granuloma
03/2000
1Hypothermia
02/2000

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
08/2001 - 08/2000
3VaccinesIBA
07/2001 - 12/2000
3MART-1 AntigenIBA
06/2001 - 07/2000
2Biological ProductsIBA
03/2015 - 06/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2005 - 11/2001
2Proteins (Proteins, Gene)FDA Link
11/2001 - 12/2000
2AntigensIBA
07/2001 - 08/2000
2Neoplasm Antigens (Tumor Antigens)IBA
07/2001 - 03/2001
2EpitopesIBA
12/2000 - 07/2000
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1LithiumIBA
02/2018
1Biomarkers (Surrogate Marker)IBA
11/2001
1Melphalan (Alkeran)FDA LinkGeneric
11/2001
1satraplatin (JM 216)IBA
06/2001
1PlatinumIBA
06/2001
1HLA-A2 Antigen (HLA A2 Antigen)IBA
03/2001
1Messenger RNA (mRNA)IBA
12/2000
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2000
1Complementary DNA (cDNA)IBA
08/2000
1Cancer VaccinesIBA
08/2000
1Minocycline (Cyclops)FDA LinkGeneric
03/2000
1Yohimbine (Yocon)IBA
02/2000

Therapy/Procedure

1Bariatric Surgery
02/2018
1Myocutaneous Flap
03/2015
1Operative Surgical Procedures
03/2015
1Lymph Node Excision (Lymph Node Dissection)
01/2013
1Neck Dissection (Radical Neck Dissection)
01/2013
1Limb Salvage
07/2005
1Immunotherapy
01/2000